Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A phase II study of bromocriptine in patients with androgen-independent prostate cancer.
Horti J, Figg WD, Weinberger B, Kohler D, Sartor O. Horti J, et al. Oncol Rep. 1998 Jul-Aug;5(4):893-6. doi: 10.3892/or.5.4.893. Oncol Rep. 1998. PMID: 9625840 Clinical Trial.
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA; TAX 327 Investigators. Tannock IF, et al. Among authors: horti j. N Engl J Med. 2004 Oct 7;351(15):1502-12. doi: 10.1056/NEJMoa040720. N Engl J Med. 2004. PMID: 15470213 Free article. Clinical Trial.
A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer.
Horti J, Widmark A, Stenzl A, Federico MH, Abratt RP, Sanders N, Pover GM, Bodrogi I. Horti J, et al. Cancer Biother Radiopharm. 2009 Apr;24(2):175-80. doi: 10.1089/cbr.2008.0588. Cancer Biother Radiopharm. 2009. PMID: 19409038 Clinical Trial.
Prostate cancer screening.
Tenke P, Horti J, Balint P, Kovacs B. Tenke P, et al. Among authors: horti j. Recent Results Cancer Res. 2007;175:65-81. doi: 10.1007/978-3-540-40901-4_5. Recent Results Cancer Res. 2007. PMID: 17432554 Review.
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer.
Horti J, Juhasz E, Monostori Z, Maeda K, Eckhardt S, Bodrogi I. Horti J, et al. Cancer Chemother Pharmacol. 2008 Jun;62(1):173-80. doi: 10.1007/s00280-007-0665-7. Epub 2008 Jan 23. Cancer Chemother Pharmacol. 2008. PMID: 18214483 Clinical Trial.
A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancer.
Senderowicz AM, Reid R, Headlee D, Abornathy T, Horti J, Lush RM, Reed E, Figg WD, Sausville EA. Senderowicz AM, et al. Among authors: horti j. Urol Int. 1999;63(2):120-5. doi: 10.1159/000030430. Urol Int. 1999. PMID: 10592501 Clinical Trial.
Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma.
Arah IN, Dixon SC, Horti J, Figg WD. Arah IN, et al. Among authors: horti j. Neoplasma. 1999;46(2):117-23. Neoplasma. 1999. PMID: 10466436
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor.
Horti J, Dixon SC, Logothetis CJ, Guo Y, Reed E, Figg WD. Horti J, et al. Br J Cancer. 1999 Mar;79(9-10):1588-93. doi: 10.1038/sj.bjc.6690253. Br J Cancer. 1999. PMID: 10188911 Free PMC article.
Methods for extracting and amplifying genomic DNA isolated from frozen serum.
Dixon SC, Horti J, Guo Y, Reed E, Figg WD. Dixon SC, et al. Among authors: horti j. Nat Biotechnol. 1998 Jan;16(1):91-4. doi: 10.1038/nbt0198-91. Nat Biotechnol. 1998. PMID: 9447601 No abstract available.
Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I, Baki M, Horti J, Géczi L, Liszka G, Ottó S, Hindy I, Eckhardt S, Sugár J. Bodrogi I, et al. Among authors: horti j. Acta Med Hung. 1994;50(3-4):275-92. Acta Med Hung. 1994. PMID: 8587840 Clinical Trial.
17 results
Jump to page